RxDoctor Payments Data

Jesse Chrastil, MD

Orthopaedic Surgery · Golden, CONPI 1982857181

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,438 of the $49,925 with a category attached, or 89.0%. Medical Device Business Services, Inc. accounts for 92.8% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $21,918, more than ten times the $397 reported in 2019.

$49,925in general payments, 2019–2025

Across 79 payments — averaging $631.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$46K
  • Zimmer Biomet$2K
  • Johnson & Johnson$726
  • Aesculap Implant Systems, LLC$416
  • Stryker$101
  • Innovation Technologies Inc$17
  • plus $30 from 2 others

What the payments were for

  • Consulting fees$44,43889%
  • Travel & lodging$1,0812%
  • Food & beverage$4,1008%
  • Education$3061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,925 in reported general payments places this provider in the 85th percentile of 383 orthopaedic surgery providers in Colorado.

See all orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$433,432
Medicare patients
577
Services billed
4,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib100$2,479
Oxycodone Hcl67$557
Methylprednisolone41$371
Tramadol Hcl106$330
Meloxicam61$154
Gabapentin14$97
Methocarbamol11$94

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Golden

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →